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a  b  s  t  r  a  c  t
Cedecea represents a genus in the Enterobacteriaceae family that has been rarely associated
with  human infection. The clinical relevance of Cedecea lapagei has yet to be elucidated. This
is  the ﬁrst reported case of pneumonia due to C. lapagei in a patient with acute promyelocytic
leukemia.
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A 34-year-old patient was  admitted to the “Area # 4 Gen-
eral  Hospital” in Monterrey, Mexico. He had a 6-day history of
asthenia,  fatigue, fever of 38 ◦C, multiple painful oral lesions
and  gum bleeding. He had been to the dentist’s ofﬁce three
days  before for management of his symptoms and was  pre-
scribed  erythromycin. The patient denied any chronic disease
and  he was  allergic to penicillin. He had smoked 20 cigarettes
per  week for 15 years and drank alcohol occasionally. On
examination, he had multiple oral ulcers with whitish bor-
ders  and petechiae around and under the tongue. The rest of
the  examination was  normal. Laboratory results showed pan-
cytopenia,  hemoglobin 8.2 g/dL, total white blood cell count
0.927  k/L and platelets 84.4 k/L.
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Este é um artigo Open Access sob a licençaOne day after admission, a bone marrow biopsy and aspi-
rate  were  performed. The patient developed melena and his
temperature  rose to 39 ◦C. Broad-spectrum antibiotic ther-
apy  was  initiated with levoﬂoxacin and imipenem, under the
suspicion  of an abdominal infectious process. Biopsy and
aspirate  results were obtained two days later, establishing
the  diagnosis of acute promyelocytic leukemia; chemotherapy
with  idarubicin, cytarabine and all-trans-retinoic acid (ATRA)
was  begun. Fever persisted for the next three days and he
developed  signs of disseminated intravascular coagulationta Especialidad #25, Monterrey, Mexico.
@gmail.com (L.A.S. Lopez).
and  acute pulmonary edema that were  successfully treated.
Two  days later, a control chest X-ray showed bilateral, cot-
tony  inﬁltrates suggesting fungal or staphylococcal infection.
 de CC BY-NC-ND
 2 0 1 
L
a
d
o
a
c
w
a
t
t
t
U
A
h
p
X
t
h
s
a
o
a
a
t
m
t
t
b
a
T
X
w
T
s
P
d
n
p
n
w
w
a
(
3
A
a
i
w
w
a
m
s
C
l
c
n
a
rb r a z j i n f e c t d i s .
evoﬂoxacin and imipenem were replaced with cefepime,
mphoterecin B, and vancomycin. He had no fever for three
ays  and appeared to be improving. The patient then devel-
ped  vomiting of gastric contents, diarrhea and diffuse, severe
bdominal  pain. A computed tomography reported ﬁndings
ompatible with neutropenic enterocolitis. Amphoterecin B
as withdrawn and treatment with metronidazole was  initi-
ted.  An exploratory laparotomy was  performed documenting
wo  liters of intra-abdominal free ﬂuid and cecum necrosis;
otal  colectomy and ileostomy were  performed. After surgery,
he  patient was  transferred to the hospital’s Intensive Care
nit  (ICU) where he developed acute renal injury, RIFLE-F.
TRA  was  withdrawn, a hemodialysis catheter was placed and
e  required mechanical ventilation by intubation.
On his second day in the ICU, the patient developed dys-
nea,  copious yellow sputum and a 40 ◦C fever. The chest
-ray  showed bilateral alveolar inﬁltrates. Two blood and spu-
um  cultures were  obtained. On the ﬁfth day in the ICU,
e  developed disseminated intravascular coagulation for a
econd time. By the sixth day, the blood cultures were neg-
tive  but the sputum cultures documented the presence
f  the Gram-negative bacterium Cedecea lapagei by VITEC 2
nalysis  (bioMérieux Inc.). The bacterium was resistant to
mikacin,  ampicillin, aztreonam, cefazolin, cefepime, cef-
riaxone,  ciproﬂoxacin, ertapenem, imipenem, meropenem,
oxiﬂoxacin, nitrofurantoin, piperacillin/tazobactam and
rimethoprim/sulfamethoxazole. It was  moderately sensitive
o  ampicillin/sulbactam, gentamicin and tobramycin. The
acterium  was  completely sensitive only to tigecycline. His
ntibiotics  were  replaced with tigecycline and vancomycin.
wo  days later, the fever and dyspnea abated and the chest
-ray  and sputum cultures were  negative by the seventh day;
e  considered that the C. lapagei pneumonia had resolved.
he  following day, the patient again developed a 38 ◦C fever
pike  and a new sputum culture revealed the presence of
seudomona  putida, sensitive to cefepime. For the next ﬁve
ays,  blood and sputum cultures were  negative and he had
o  fever, so dexamethasone was  added to his chemotherapy
rotocol. The next day, he presented severe gastrointesti-
al and pulmonary bleeding that was  successfully treated
ith  fresh frozen plasma. Five days later, cefepime was
ithdrawn and the endotracheal cannula was  replaced with
 tracheostomy. Upon clinical and laboratory improvement
hemoglobin 11.2 g/dL, total leukocyte count 14 k/L, platelets
31  k/L), he was  transferred to the Internal Medicine ﬂoor.
fter  nine days of clear clinical improvement, the patient
gain  had fever and symptoms suggesting a urinary tract
nfection;  the urinary catheter was  removed and treatment
ith  imipenem and levoﬂoxacin was  initiated. After 72 hours
ith  no fever, the patient was  released; he was  stable and
symptomatic and was  referred to the Hematology Depart-
ent  for follow-up.
Cedecea  is a genus in the Enterobacteriaceae family. Six
trains  have been identiﬁed: Cedecea davisae, C. lapagei, C. neteri,
. species 3, C. species 5 and C. species 6. Only C. davisae, C.
apagei,  C. neteri and C. species 6 have been known to, rarely,
1–9ause  infections in humans.
Morphologically, C. lapagei is a short and mobile Gram-
egative bacillus. It is catalase-positive, oxidase-negative,
rabinose-negative, arginine-positive, it reduces nitrates to3;1 7(5):626–628  627
nitrites, blackens esculin iron agar and produces acid with d-
arabitol, cellobiose, maltose, d-mannitol, d-mannose, salicin
and  trehalose.10 C. lapagei can be distinguished from other
Cedecea  strains by its ability to grow in media lacking thiamine
and  because it is quickly detected in the Voges–Proskauer test
following  the O’ Meara method.11
C. lapagei has been identiﬁed as a human pathogen on
three  occasions.6,12,13 The ﬁrst infection was  reported at the
Veterans Affairs Medical Center at the University of Ten-
nessee  Center for Health Sciences, in a peritoneal ﬂuid sample
obtained  from a 55-year-old patient after a liver transplant.
The  infection in this immunocompromised host was suc-
cessfully  treated with vancomycin and gentamicin, as well
as  ceftazidime and gentamicin added to the peritoneal dial-
ysis  solution.12 The second case involved a patient with
bacteremia after a chemical burn with cement and type II dia-
betes  mellitus. The bacteremia and the wound infection were
both  successfully treated with cefotaxime and amikacin.6 The
third  report was  of a Turkish patient with chronic obstructive
pulmonary disease and subarachnoid hemorrhage that devel-
oped  pneumonia due to C. lapagei, apparently due to secretion
aspiration from the upper respiratory tract. The patient had
a  good clinical response to meropenem and amikacin therapy
but  subsequently died due to the subarachnoid hemorrhage.13
Our case is the fourth report of C. lapagei infection and the
second  case of pneumonia. All four patients had risk factors
for  opportunistic infection (acute leukemia, liver transplant,
type  2 diabetes mellitus and chronic obstructive pulmonary
disease). Laboratory results in three cases conﬁrmed the suc-
cessful  treatment of the infections and the fourth patient died
before  this information was  available.6,12,13
This is the ﬁrst case report of pneumonia due to C. lapagei
in  Mexico, in an immunocompromised patient with a hos-
pital  course complicated by multiple infections. However, an
important limitation in our study is the lack of pathogen iden-
tiﬁcation  by molecular techniques since these are not available
in  our hospital.
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